Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 16Oropharyngeal Neoplasms 10Nasopharyngeal Carcinoma 10Prostatic Neoplasms 7Laryngeal Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Hypopharyngeal Neoplasms 5Head and Neck Neoplasms 5Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nasopharyngeal Neoplasms 2Mesothelioma 2Epstein-Barr Virus Infections 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Anus Neoplasms 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomatitis 1Stomach Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 25Temozolomide 19Specimen Handling 14Radiotherapy 12Biopsy 9X-Rays 8trametinib 6Radiation 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Bevacizumab 5larotrectinib 4erdafitinib 4dabrafenib 4abemaciclib 4Cyclophosphamide 4ulixertinib 3pembrolizumab 3palbociclib 3olaparib 3Surgical Procedures, Operative 3Nivolumab 3tipifarnib 2tazemetostat 2selpercatinib 2mirdametinib 2lutetium Lu 177 dotatate 2ivosidenib 2fluorodopa F 18 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Radiotherapy, Intensity-Modulated × 90 days × Clear all
NCT03180502 2026-05-26

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NRG Oncology

Phase 2 Active not recruiting
120 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡